11 March 2019 | News
This integration allows Eversense CGM data to be synced into Glooko’s platform directly from the Senseonics cloud.
image credit- pharmaphorum.com
Senseonics Holdings, Inc., a US based medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, has announced the integration of Eversense CGM data into the Glooko diabetes data management platform.
This integration allows Eversense CGM data to be synced into Glooko’s platform directly from the Senseonics cloud. Eversense users will be able to view historical glucose and related data both in Glooko’s Mobile and Web Apps while continuing to get real-time readings from their Eversense Mobile App. Healthcare professionals can now view their patients’ data in the Glooko Population Tracker in interactive reports alongside other data residing in Glooko.
The Eversense CGM System consists of a fluorescence-based sensor, a smart transmitter worn over the sensor to facilitate data communication, and a mobile app for displaying glucose values, trends and alerts. In addition to featuring the first long-term and first implantable CGM sensor, the system is also first to feature a smart transmitter that provides wearers with discreet on-body vibratory alerts for high and low glucose and that can be removed, recharged and re-adhered without discarding the sensor. The sensor is inserted subcutaneously in the upper arm by a health care provider via a brief in-office procedure.